Symptom Severity and Its Effect on Health-related Quality of Life over Time in Patients with Pulmonary Hypertension: a Multisite Longitudinal Cohort Study

Overview

Journal BMJ Open Respir Res

Date 2018 Mar 14

PMID 29531745

Citations 22

Authors

Janelle Yorke

Christi Deaton

Malcolm Campbell

Linda McGowen

Paul Sephton

David G Kiely

Iain Armstrong

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of this cohort study was to examine health-related quality of life (HRQoL) and symptomatology in patients with pulmonary hypertension (PH) and explore factors that influence its evolution over time.

Methods: A prospective longitudinal multisite cohort study. Participants were recruited from specialist UK PH centres and completed a questionnaire pack at baseline, 6, 12 and 18 months to assess HRQoL (emPHasis-10), dyspnoea, fatigue, sleep, anxiety and depression.

Results: 185 patients entered the study at baseline and 126 (68%) completed month 18. At baseline, patients had significant impairment of HRQoL, anxiety, depression, dyspnoea and severe fatigue. No significant changes, apart from a reduction in the Hospital Anxiety and Depression Scale-Anxiety score (P=0.04), were observed over 18 months. Depression and dyspnoea were predictors of HRQoL (P=0.002 and P=0.03, respectively). Oxygen use was also associated with diminished HRQoL and increased symptom severity.

Conclusion: Patients with PH experience high levels of symptom severity and the negative impact on HRQoL was unchanged over time. The use of oxygen therapy, in particular, was associated with a significant impact on HRQoL. Further study of factors impacting HRQoL and interventions that target a combination of physiological and psychosocial consequences of living with PH are needed.

Citing Articles

The Role of Cardiac MRI in Pulmonary Hypertension- Is it Still an Underutilized Tool.

Banjade P, Subedi A, Acharya S, Itani A, Sharma M, Kassam N Open Respir Med J. 2024; 18:e18743064288565.

PMID: 39136034 PMC: 11318157. DOI: 10.2174/0118743064288565240515115239.

Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange event.

Tackney M, Steele A, Newman J, Fritzsche M, Lucivero F, Khadjesari Z Trials. 2024; 25(1):521.

PMID: 39095915 PMC: 11297702. DOI: 10.1186/s13063-024-08356-7.

Interactions between Cognitive, Affective, and Respiratory Profiles in Chronic Respiratory Disorders: A Cluster Analysis Approach.

Buican I, Gheorman V, Udristoiu I, Olteanu M, Radulescu D, Calafeteanu D Diagnostics (Basel). 2024; 14(11).

PMID: 38893678 PMC: 11171769. DOI: 10.3390/diagnostics14111153.

The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension.

Kronberger C, Willixhofer R, Mousavi R, Grzeda M, Litschauer B, Krall C PLoS One. 2024; 19(5):e0301483.

PMID: 38809846 PMC: 11135673. DOI: 10.1371/journal.pone.0301483.

Exploratory and confirmatory factor analysis of emPHasis-10: The health-related quality-of-life measure in pulmonary hypertension.

Rawlings G, Gaskell C, Beail N, Thompson A, Armstrong I Pulm Circ. 2024; 14(2):e12378.

PMID: 38736895 PMC: 11088805. DOI: 10.1002/pul2.12378.

References

Lacasse Y, Bernard S, Martin S, Boivin M, Maltais F . Utility Scores In Patients With Oxygen-Dependent COPD: A Case-Control Study. COPD. 2015; 12(5):510-5. DOI: 10.3109/15412555.2014.995290. View

Yorke J, Armstrong I, Bundock S . Impact of living with pulmonary hypertension: a qualitative exploration. Nurs Health Sci. 2014; 16(4):454-60. DOI: 10.1111/nhs.12138. View

Jason L, Evans M, Brown M, Porter N, Brown A, Hunnell J . Fatigue Scales and Chronic Fatigue Syndrome: Issues of Sensitivity and Specificity. Disabil Stud Q. 2011; 31(1). PMC: 3181109. View

Kellner R, Samet J, Pathak D . Dyspnea, anxiety, and depression in chronic respiratory impairment. Gen Hosp Psychiatry. 1992; 14(1):20-8. DOI: 10.1016/0163-8343(92)90022-3. View

Stewart A, Hays R, Ware Jr J . The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988; 26(7):724-35. DOI: 10.1097/00005650-198807000-00007. View

Delcroix M, Howard L . Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev. 2015; 24(138):621-9. PMC: 9487616. DOI: 10.1183/16000617.0063-2015. View

White J, Hopkins R, Glissmeyer E, Kitterman N, Elliott C . Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res. 2006; 7:55. PMC: 1448205. DOI: 10.1186/1465-9921-7-55. View

McDonough A, Matura L, Carroll D . Symptom experience of pulmonary arterial hypertension patients. Clin Nurs Res. 2010; 20(2):120-34. DOI: 10.1177/1054773810391249. View

Lowe B, Grafe K, Ufer C, Kroenke K, Grunig E, Herzog W . Anxiety and depression in patients with pulmonary hypertension. Psychosom Med. 2004; 66(6):831-6. DOI: 10.1097/01.psy.0000145593.37594.39. View

10.

Flattery M, Pinson J, Savage L, Salyer J . Living with pulmonary artery hypertension: patients' experiences. Heart Lung. 2005; 34(2):99-107. DOI: 10.1016/j.hrtlng.2004.06.010. View

11.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

12.

Galie N, Barbera J, Frost A, Ghofrani H, Hoeper M, McLaughlin V . Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med. 2015; 373(9):834-44. DOI: 10.1056/NEJMoa1413687. View

13.

Matura L, McDonough A, Carroll D . Health-related quality of life and psychological states in patients with pulmonary arterial hypertension. J Cardiovasc Nurs. 2012; 29(2):178-84. DOI: 10.1097/JCN.0b013e318275330d. View

14.

Goldbart J, Yohannes A, Woolrych R, Caton S . 'It is not going to change his life but it has picked him up': a qualitative study of perspectives on long term oxygen therapy for people with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013; 11:124. PMC: 3750579. DOI: 10.1186/1477-7525-11-124. View

15.

Rubenfire M, Lippo G, Bodini B, Blasi F, Allegra L, Bossone E . Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. Chest. 2009; 136(2):597-603. DOI: 10.1378/chest.08-1260. View

16.

Arnold E, Bruton A, Donovan-Hall M, Fenwick A, Dibb B, Walker E . Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study. BMC Pulm Med. 2011; 11:9. PMC: 3045998. DOI: 10.1186/1471-2466-11-9. View

17.

Matura L, McDonough A, Carroll D . Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension. J Pain Symptom Manage. 2015; 51(1):25-32. PMC: 4698220. DOI: 10.1016/j.jpainsymman.2015.07.012. View

18.

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Respir J. 2015; 46(4):903-75. DOI: 10.1183/13993003.01032-2015. View

19.

Mathai S, Suber T, Khair R, Kolb T, Damico R, Hassoun P . Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2015; 13(1):31-9. PMC: 4722843. DOI: 10.1513/AnnalsATS.201412-572OC. View

20.

Talwar A, Sahni S, Kim E, Verma S, Kohn N . Dyspnea, depression and health related quality of life in pulmonary arterial hypertension patients. J Exerc Rehabil. 2015; 11(5):259-65. PMC: 4625654. DOI: 10.12965/jer.150230. View